Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 36 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III DES vs TMX for Postmenopausal ER-Positive or ER-Unknown Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-79BRE334


2.		Phase III Chemotherapy with ADR/CTX/CACP Followed by Orchiectomy or Hormone Therapy with DES for Chemotherapy Failures with Metastatic Prostatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 70								NCI-78-C-56 NCI-NMOB-814

Last Modified: 7/13/2007


3.		Phase III Pelvic Irradiation vs Pelvic and Para-aortic Irradiation for Stage A2/B/C Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				RTOG-7506 RTOG-75-06


4.		Phase III Randomized Adjuvant Chemotherapy with CTX/DES vs DES Alone Following Surgery or Radiotherapy for Stage A2/B/C Prostatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-GU-81330


5.		Phase III Randomized Comparison of DES/LEV vs DES Alone in Stage C/D Prostatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-D82-012-793 ICC-81U4


6.		Phase III DES or Orchiectomy vs CTX/5-FU plus DES or Orchiectomy vs Estracyt for Stage D2 Prostate Cancer without Prior Endocrine Therapy or Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NPCTG-1300


7.		Phase III Orchiectomy or DES with or without CTX/5-FU for Stable Stage D Cancer of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NPCTG-1400


8.		Phase III MEG vs MEG/DES vs Stilphostrol vs STZ for Previously Irradiated Hormone-Refractory Metastatic Prostatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NPCTG-1600

Last Modified: 12/1/1997


9.		Phase III Randomized Comparison of DES or Orchiectomy vs Buserelin vs DES/MTX or Orchiectomy/MTX in Newly Diagnosed Clinical Stage D2 Carcinoma of the Prostate with No Prior Chemotherapy or Hormonal Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								NPCTG-1700

Last Modified: 7/1/1997


10.		Phase III Combined vs Sequential ADR/CTX and Orchiectomy or DES for Stage D or Refractory Adenocarcinoma of the Prostate (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-8219

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute